The latest report Urinary Incontinence Pipeline Highlights – 2015, provides most up-to-date information on key pipeline molecules in the global Urinary Incontinence market. It covers emerging therapies for Urinary Incontinence in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Urinary Incontinence pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Urinary Incontinence pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.
Company:
The report provides Urinary Incontinence pipeline molecules by the Originator Company.
Short-term Launch Highlights:
Find out which Urinary Incontinence pipeline products will be launched in the US and Ex-US till 2017.
SUMMARY:
- Urinary Incontinence phase 3 clinical trial pipeline molecules
- Urinary Incontinence phase 2 clinical trial pipeline molecules
- Urinary Incontinence phase 1 clinical trial pipeline molecules
- Urinary Incontinence preclinical research pipeline molecules
- Urinary Incontinence discovery stage pipeline molecules
- Urinary Incontinence pipeline molecules short-term launch highlights
1. Urinary Incontinence Pipeline by Stages
2. Urinary Incontinence Pipeline by Drug Class
3. Urinary Incontinence Pipeline by Company
4. Urinary Incontinence Phase 3 Clinical Trial Insights
5. Urinary Incontinence Phase 2 Clinical Trial Insights
6. Urinary Incontinence Phase 1 Clinical Trial Insights
7. Urinary Incontinence Preclinical Research Insights
8. Urinary Incontinence Discovery Stage Insights
9. Appendix
10. Research Methodology
Table 1: Urinary Incontinence Phase 3 Clinical Trials, 2015
Table 2: Urinary Incontinence Phase 2 Clinical Trials, 2015
Table 3: Urinary Incontinence Phase 1 Clinical Trials, 2015
Table 4: Urinary Incontinence Preclinical Research, 2015
Table 5: Urinary Incontinence Discovery Stage, 2015
Figure 1: Urinary Incontinence Pipeline Molecules by Clinical Trials Stage, 2015
Figure 2: Urinary Incontinence Pipeline Molecules by Drug Class, 2015
Figure 3: Urinary Incontinence Pipeline Molecules by Company, 2015
Figure 4: Urinary Incontinence Phase 3 Clinical Trial Highlights, 2015
Figure 5: Urinary Incontinence Phase 2 Clinical Trial Highlights, 2015
Figure 6: Urinary Incontinence Phase 1 Clinical Trial Highlights, 2015
Figure 7: Urinary Incontinence Preclinical Research Highlights, 2015
Figure 8: Urinary Incontinence Discovery Stage Highlights, 2015
Countries Covered:
Global, Europe, The US, Germany, France, UK, Spain, Italy, and Japan
For more information please click on:
http://www.researchandmarkets.com/publication/mv1w772/urinary_incontinence_pipeline
Pricing:
Electronic (Single User): EUR 619
CD ROM: EUR 721
Hard Copy: EUR 739
Electronic (Site License): EUR 1857
Electronic (Enterprisewide): EUR 3714
Ordering - Three easy ways to place your order:
1] Order online: Please click here to order online from our website
2] Order by fax: Please click here to print an order form that you can fax to +353 1 4100 980
3] Order by mail: Please click here to print an order form that you can post to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.
Thank you for your consideration.
Best Regards,
Rachel Thompson
Senior Manager
Research and Markets Ltd
rachel.thompson@researchandmarkets.com